The Ketogenic Diet: Clinical Applications, Evidence-based Indications, and Implementation

Excerpt

The ketogenic diet is a high-fat, very low-carbohydrate, and moderate-protein dietary approach designed to induce nutritional ketosis. In this metabolic state, the body shifts from glucose to ketone bodies as its primary energy source. Typical macronutrient distribution includes about 55% to 60% fat, 30% to 35% protein, and 5% to 10% carbohydrates. This shift alters glucose utilization, enhances ketone production, and improves insulin sensitivity, which underlie the ketogenic diet's therapeutic and metabolic benefits.

Before the discovery of insulin in the 1920s, managing type 1 diabetes mainly involved very low-carbohydrate, low-calorie diets that were essentially ketogenic. These diets aimed to prolong survival by reducing glycosuria and hyperglycemia but often caused severe malnutrition and growth impairment, especially in children. The introduction of exogenous insulin in the 1920s replaced dietary measures as the primary treatment for diabetes. Russell Wilder, MD of the Mayo Clinic, first used the ketogenic diet to treat epilepsy in 1921. He coined the term "ketogenic diet" and observed that it reduced the frequency and severity of seizures in some of his patients who followed it. The ketogenic diet saw a decline in clinical use after the discovery of insulin and the development of anticonvulsant medications. The diet's resurgence in the 1990s was driven by renewed success in treating refractory epilepsy, later expanding to include treating a range of cardiometabolic and neurologic conditions.

Today, the ketogenic diet is studied and used in various clinical and research settings, including obesity, metabolic syndrome, and type 2 diabetes, with growing interest in areas like cancer metabolism and neurodegenerative diseases, including Parkinson disease and Alzheimer disease. Multiple randomized controlled trials and meta-analyses have demonstrated its effectiveness for weight loss and blood sugar control in obesity and type 2 diabetes, resulting in reductions in body mass index, hemoglobin A1c, and triglycerides, and increased high-density lipoprotein cholesterol. Further evidence indicates improvements in insulin sensitivity and metabolic parameters in metabolic syndrome.

Although current use of the ketogenic diet includes metabolic and neurologic disorders, epilepsy remains its only universally accepted, guideline-supported indication. The diet is well established in managing drug-resistant epilepsy, glucose transporter type 1 deficiency syndrome, and pyruvate dehydrogenase deficiency, where it can substantially reduce seizure frequency and severity. Emerging applications in obesity, diabetes, metabolic dysfunction–associated steatotic liver disease, and neurodegenerative conditions remain investigational and lack guidelines from professional medical organizations. Other areas of investigation include supportive therapy for certain cancers, polycystic ovary syndrome, and psychiatric conditions, but current evidence is limited.

Three principal forms of the ketogenic diet are used in clinical practice, differing in composition, level of restriction, and therapeutic goals.

1. The traditional ketogenic diet, initially developed for treating drug-resistant epilepsy (especially in children), is a ratio-based plan where the amount of fat relative to combined protein and carbohydrate is typically 4:1; in some cases, a 3:1 ratio can be used. About 90% of total calories come from fat, with approximately 6% from protein and 4% from carbohydrates. This diet requires precise food weighing and close supervision by medical professionals and dietitians to maintain ketosis. The main goal is to achieve and sustain high, stable ketone levels to reduce seizure frequency and severity.

2. The modified Atkins diet provides a less restrictive alternative, often used for adolescents and adults with epilepsy or when strict adherence to the traditional plan is difficult. This diet employs an approximate 1:1 ratio of fat to combined protein and carbohydrates by weight, resulting in roughly 60% to 70% of calories from fat, 25% to 30% from protein, and 5% to 10% from carbohydrates (usually less than 20 grams daily). Foods do not need to be weighed, making this approach more straightforward to implement while still promoting nutritional ketosis.

3. The very-low-carbohydrate ketogenic diet is most often prescribed for obesity, type 2 diabetes, and metabolic syndrome. Instead of following a fixed macronutrient ratio, it limits carbohydrate intake to 20 to 50 grams daily, with moderate protein and 60% to 75% of calories from fat. This dietary pattern emphasizes carbohydrate restriction as the primary driver of ketosis, offering greater flexibility and long-term sustainability. The primary clinical goals are weight loss, improved insulin sensitivity, and favorable metabolic effects.

This educational activity explores the physiological mechanisms, clinical applications, and potential risks of the ketogenic diet, along with team-based strategies for its implementation, emphasizing evidence-based, patient-centered care across healthcare professions.